ALIVIO THERAPEUTICS

alivio-therapeutics-logo

Alivio Therapeutics is pioneering targeted disease immunomodulation as a novel strategy to treat a range of chronic and acute inflammatory disorders. Targeted disease immunomodulation involves tuning the immune system exclusively at the site of disease in the body, with minimal impact on the rest of the immune system. This long sought-after approach has potential to treat a range of chronic and acute inflammatory disorders including ones that would otherwise be difficult to treat. Alivio has exc... lusive rights to a proprietary inflammation-targeting technology, based on the research of Dr. Karp (BWH/HMS) and Dr. Robert Langer (MIT), which is the first technology to reproducibly show the ability to target immunomodulatory compounds to inflamed tissue, which can lead to dramatic improvements in treatment efficacy with major reductions in systemic effects. The platform has been validated in multiple labs and preclinical models of inflammation, including models where the inflammation occurred in different parts of the body (e.g., the GI system, the bladder, joints, skin, etc.). The technology could potentially be used with a variety of medications (e.g., small molecules, biologics, and nucleic acids) both independently or in combination, and is designed to be administered orally or via other routes. With this platform, Alivio aims to address the dozens of conditions where inflammation is a central part of the underlying disease pathology, but where targeted and effective treatment options are lacking.

#SimilarOrganizations #People #Financial #Website #More

ALIVIO THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2016-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.aliviotherapeutics.com

Total Employee:
11+

Status:
Active

Total Funding:
3.3 M USD

Technology used in webpage:
Euro Canadian Server Location


Similar Organizations

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

harry-leider_image

Harry Leider Board Member @ Alivio Therapeutics
Board_member
2020-01-01

Current Employees Featured

jeff-karp_image

Jeff Karp
Jeff Karp Co-Founder, Scientific Advisory Board Member, and Board Observer @ Alivio Therapeutics
Co-Founder, Scientific Advisory Board Member, and Board Observer
2016-05-01

Founder


jeff-karp_image

Jeff Karp

Investors List

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Alivio Therapeutics

Official Site Inspections

http://www.aliviotherapeutics.com

  • Host name: 104.21.82.131
  • IP address: 104.21.82.131
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Alivio Therapeutics"

Alivio Therapeutics - Crunchbase Company Profile & Funding

Alivio Therapeutics is pioneering targeted disease immunomodulation as a novel strategy to treat a range of chronic and acute inflammatory disorders. Targeted disease immunomodulation โ€ฆSee details»

Alivio Therapeutics Company Profile 2024: Valuation, โ€ฆ

Alivio Therapeutics is headquartered in Boston, MA. What is the size of Alivio Therapeutics? Alivio Therapeutics has 7 total employees. What industry is Alivio Therapeutics in? Alivio Therapeuticsโ€™s primary industry is Biotechnology. Is โ€ฆSee details»

Alivio Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Alivio Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 news, Drug:ALV-306, ALV-304, LYT-500, IMB-150.See details»

Alivio Therapeutics - VentureRadar

Alivio Therapeutics Follow Following Location: USA. Founded in 2016 " Alivio is pioneering a novel strategy to treat inflammatory diseases based on modulating the immune system at the โ€ฆSee details»

ALIVIO THERAPEUTICS, INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ALIVIO THERAPEUTICS, INC. of Cambridge, MA. Get the latest business insights from Dun & โ€ฆSee details»

Alivio Therapeutics Company Profile -Sales, Contacts, Competitors ...

Alivio Therapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for โ€ฆSee details»

Alivio Therapeutics - Products, Competitors, Financials, Employees ...

Alivio Therapeutics develops a novel strategy to treat inflammatory disorders through targeted disease immunomodulation and by selectively restoring immune homeostasis at inflamed sites โ€ฆSee details»

Alivio Therapeutics - Craft

Alivio Therapeutics is a biotechnology company building a strategy to treat inflammatory diseases based on modulating the immune system at the site of disease. It develops a proprietary โ€ฆSee details»

Alivio Therapeutics - Funding, Financials, Valuation & Investors

Alivio Therapeutics is pioneering a new way to treat inflammatory diseases based on precisely tuning the immune system. Search Crunchbase. Start Free Trial . ... How much funding has โ€ฆSee details»

Alivio Therapeutics, Inc.:Company Profile & Technical Research ...

Alivio Therapeutics, Inc. is a company that provides Medicine, Immune system, Inflammation and more. Alivio Therapeutics, Inc. is headquartered in United States Massachusetts. Alivio โ€ฆSee details»

Alivio Therapeutics - Crunchbase

Alivio Therapeutics is pioneering a new way to treat inflammatory diseases based on precisely tuning the immune system. Search Crunchbase. Start Free Trial . Chrome Extension. โ€ฆSee details»

Alivio Therapeutics | Company Profile | Pharmacompass.com

Find Suppliers : API/FDF. Search Our Integrated Database ; Services. Questionnaire For Your Search - Analytical - Analytical Method Development - Biologic Drugs - Capillary โ€ฆSee details»

Nextsource | Company Profile | Alivio Therapeutics

Monitor if Alivio Therapeutics is shifting their marketing strategy based on recent ad campaigns or rebranding efforts. Track key 'champions' at Alivio Therapeutics as they move through different โ€ฆSee details»

Alivio Therapeutics Information - RocketReach

The NAICS codes for Alivio Therapeutics are [325, 3254, 32, 32541]. What is the SIC code for Alivio Therapeutics? The SIC codes for Alivio Therapeutics are [283, 28]. Related Companies โ€ฆSee details»

Alivio Therapeutics | VentureRadar

Find out more about Alivio Therapeutics, Drug Delivery and Drug Delivery and Formulation. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) Funding Deals Hub; โ€ฆSee details»

Alivio Therapeutics - Company Profile - Tracxn

Alivio Therapeutics - Drug delivery gel to treat chronic and acute inflammation.. from 1 investor. Founded by Jeffrey Karp in the year 2016. Alivio Therapeutics has 3139 competitors.See details»

Aliviotherapeutics.com Website Location: Canada CA - IP-Tracker.org

Aliviotherapeutics.com, with hostname set to 155.ip-142-44-246.net, is assigned a CA country IP address 142.44.246.155 (ASN: ... (ISP / Organization) on a daily basis, which contributes to โ€ฆSee details»

PureTech buys out Alivio, adding inflammatory disease programs โ€ฆ

Jun 23, 2021 Four years after launching Alivio Therapeutics, PureTech Health is bringing the hydrogel player back into the fold by acquiring the remaining 22% of the company. Through โ€ฆSee details»

Alivio Therapeutics - Contacts, Employees, Board Members

Alivio Therapeutics has 1 current employee profile, Co-Founder, Scientific Advisory Board Member, and Board Observer Jeff Karp. Jeff Karp Co-Founder, Scientific Advisory Board โ€ฆSee details»

PureTech buys out Alivio, adding inflammatory disease programs โ€ฆ

Jun 16, 2021 Four years after launching Alivio Therapeutics, PureTech Health is bringing the hydrogel player back into the fold by acquiring the remaining 22% of the company.See details»

linkstock.net © 2022. All rights reserved